# RHEIA (Randomized researcH in womEn All Comers With Aortic Stenosis)

> **NCT04160130** · NA · UNKNOWN · sponsor: **Optimapharm** · enrollment: 432 (actual)

## Conditions studied

- Aortic Valve Stenosis
- Heart Valve Diseases

## Interventions

- **PROCEDURE:** Transcatheter aortic valve replacement

## Key facts

- **NCT ID:** NCT04160130
- **Lead sponsor:** Optimapharm
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-11-29
- **Primary completion:** 2024-02
- **Final completion:** 2024-06
- **Target enrollment:** 432 (ACTUAL)
- **Last updated:** 2023-06-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04160130

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04160130, "RHEIA (Randomized researcH in womEn All Comers With Aortic Stenosis)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04160130. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*